Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

PXF Invesco FTSE RAFI Developed Markets ex-U.S. ETF ...

Former NFL referee Dan Schachner, who has ruled as Puppy Bowl human "Rufferee" with bad dog puns and mock penalty flags since 2012, assures USA TODAY that Rocky is gonna fly now. The doe-eyed ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Read more about us Over a million Coloradans turn to Rocky Mountain PBS to discover provocative and inspiring local, national and international programming; find diverse viewpoints; score front row ...

Although the couple’s other kids from their previous relationships grew up in the spotlight, they’re taking a bit of a different approach with little Rocky. Whenever Rocky is featured in one ...

At close: February 6 at 12:55:43 p.m. EST ...

As of February 6 at 11:21:49 a.m. EST. Market Open.

As of 7 February at 3:36:03 pm GMT-5. Market open.